ArticleActa gastroenterologica Latinoamericana
[Prevalence of Anxiety and Depression in Patients with Inflammatory Bowel Disease: Association with Disease Activity and its Impact on Quality of Life].
Article in Acta gastroenterologica Latinoamericana. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Inflammatory bowel diseases are chronic conditions whose digestive and extradigestive symptoms affect patients' quality of life. Multiple observational studies have also reported a significantly higher prevalence of psychiatric disorders, particularly anxiety and depression, in inflammatory bowel disease patients compared to the general population. Objectives: To evaluate the prevalence of symptoms suggestive of anxiety and/or depression in inflammatory bowel disease patients, as well as their association with disease activity and quality of life. Materials and methods: Patients over 18 years of age who attended the inflammatory bowel disease clinics of the Gastroenterology and Hepatology Service of the Güemes Hospital and the Centro Integral de Gastroenterología, in the Autonomous City of Buenos Aires, Argentina, from May 2023 to April 2025 were evaluated. The HADS (Hospital Anxiety and Depresión Scale) and CCVEII-9 (Shortened quality of life questionnaire in inflammatory bowel disease) questionnaires were administered, alongside the collection of clinical data and fecal calprotectin as a marker of inflammatory activity. Results: Ninety-nine patients with inflammatory bowel disease aged 18 years or older were included. Symptoms suggestive of anxiety were observed in 62.6% and depression in 19% of patients. No significant associations were found between psychiatric symptoms and calprotectin levels. However, the presence of anxiety or depression was associated with lower quality of life. Moderate negative correlations were observed for anxiety and strong negative correlations for depression between the scores of the two questionnaires. Conclusion: More than half of inflammatory bowel disease patients present symptoms of anxiety and depression, significantly affecting their quality of life, although no relationship with inflammatory activity was observed. These findings emphasize the importance of screening and specifically treating psychiatric disorders in this population to improve overall wellbeing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.